We just completed a short note on Ceres which is still marketing their IPO. The company has licensed IP from a few sources and combined with their own substantial investments in R&D to create bioengineered or genetically modified (GMO) seeds.
The first market for Ceres is Brazil where biofuels are already big and Ceres has a crop (sorghum) that extends the growing season and adds much-needed supply to that market.
In addition to their own strain of sweet sorghum the company has over 300 patents issued and pending on a variety of plants engineered to grow faster and/or with more density – in some cases only irrigated with sea water.
This is an early-stage company so suitable only for long-term investors. If the company can execute over the next several years the shares can support an IV of $65 versus the proposed $22 mid-point of the range.
Please access the report on our research page for more information.
